Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study

Katharina Tabea Jungo, Cynthia M. Boyd, Barbara Farrell, Caroline McCarthy

Open source

DOI
10.1111/bcpt.70176
Published
2025-12-11
Container
Basic & Clinical Pharmacology & Toxicology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcpt.70176,
  title = {Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study},
  author = {Katharina Tabea Jungo and Cynthia M. Boyd and Barbara Farrell and Caroline McCarthy},
  year = {2025},
  journal = {Basic \& Clinical Pharmacology \& Toxicology},
  doi = {10.1111/bcpt.70176},
  url = {https://doi.org/10.1111/bcpt.70176}
}

RIS

TY  - JOUR
TI  - Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study
AU  - Katharina Tabea Jungo
AU  - Cynthia M. Boyd
AU  - Barbara Farrell
AU  - Caroline McCarthy
PY  - 2025
JO  - Basic & Clinical Pharmacology & Toxicology
DO  - 10.1111/bcpt.70176
UR  - https://doi.org/10.1111/bcpt.70176
ER  - 

APA

Jungo, K. T., Boyd, C. M., Farrell, B., & McCarthy, C. (2025). Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70176

Source records